Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.

Eitemau Tebyg

• Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
  gan: Ogg, G, et al.
  Cyhoeddwyd: (1999)
• Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
  gan: Feeney, M, et al.
  Cyhoeddwyd: (2004)
• Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
  gan: Borrow, P, et al.
  Cyhoeddwyd: (1994)
• Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.
  gan: Goulder, P, et al.
  Cyhoeddwyd: (1997)
• Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
  gan: Goulder, P, et al.
  Cyhoeddwyd: (2000)